Alibaba: High Hopes and Regulatory Hurdles

The recent developments surrounding Alibaba Group Holding Ltd. have captured significant attention, following the company’s decision to abandon its plans for the spin-off and IPO of its cloud computing division. This announcement, which coincided with the release of its quarterly earnings last Thursday, prompted a 10% drop in Alibaba’s share price. The reaction from Wall Street analysts has been varied, with some expressing concern over the strategic direction of the company, while others maintain a positive outlook.

Read more

Elon Musk Versus the Board: Who Will Swallow the “Poison Pill” in the Battle for Twitter?

A collage of Elon Musk and Twitter's mobile app

Sources: Unsplash, Pixabay | Author: DeltaStock

Reading time: 3 minutes

Twitter’s board of directors armed itself against a potential aggressive buyout a mere day after the billionaire entrepreneur Elon Musk offered to buy the social network for $43 billion. The company’s management then approved a shareholder rights plan with a limited duration, better known as the “poison pill”.

Here’s what Ivaylo Chaushev, chief financial analyst of DeltaStock, makes of the whole situation and where it could be headed next.

Read more

Is a V-shaped Economic Recovery Still a Possibility?

Графично представяне на COVID-19

Source: Pixabay | Owner: MasterTux

Reading time: six minutes

The world has entered the second half of 2020 just as troubled (if not more so) as it did in the first half. And as financial forecasts grow grimmer by the day, one thing is starting to become painfully clear to all—we might not see a full recovery in 2020, and even one happening in 2021 would depend on a lot going right.

Read more